270 related articles for article (PubMed ID: 11500061)
21. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
Natarajan Y; Patel P; Chu J; Yu X; Hernaez R; El-Serag H; Kanwal F
Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703
[TBL] [Abstract][Full Text] [Related]
22. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
[TBL] [Abstract][Full Text] [Related]
23. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?
Fracanzani AL; Borzio M; Roncalli M; Derenzini M; Trerè D; Mattioli M; Taioli E; Fiorelli G; Fargion S
Am J Gastroenterol; 2000 Oct; 95(10):2940-5. PubMed ID: 11051372
[TBL] [Abstract][Full Text] [Related]
24. HFE haemochromatosis gene mutations in liver transplant patients.
Halme L; Heliö T; Mäkinen J; Höckerstedt K; Färkkilä M; Piippo K; Krusius T; Kontula K
Scand J Gastroenterol; 2001 Aug; 36(8):881-5. PubMed ID: 11495086
[TBL] [Abstract][Full Text] [Related]
25. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
26. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
27. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
Shiono Y; Ikeda R; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Imaizumi Y; Yano M; Yoshioka K; Kawanaka M; Yamada G
Intern Med; 2001 Sep; 40(9):852-6. PubMed ID: 11579943
[TBL] [Abstract][Full Text] [Related]
28. [Genetic hemochromatosis and the HFE gene].
Moirand R
Bull Acad Natl Med; 2000; 184(2):325-35; discussion 335-6. PubMed ID: 10989541
[TBL] [Abstract][Full Text] [Related]
29. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
[TBL] [Abstract][Full Text] [Related]
30. [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].
Ropero P; Briceño O; López-Alonso G; Agúndez JA; González Fernández FA; García-Hoz F; Villegas Martínez A; Díaz-Rubio M; Ladero JM
Rev Esp Enferm Dig; 2007 Jul; 99(7):376-81. PubMed ID: 17973580
[TBL] [Abstract][Full Text] [Related]
31. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
[TBL] [Abstract][Full Text] [Related]
32. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
[TBL] [Abstract][Full Text] [Related]
33. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and clinical significance of HFE gene mutations in patients with iron overload.
Brandhagen DJ; Fairbanks VF; Baldus WP; Smith CI; Kruckeberg KE; Schaid DJ; Thibodeau SN
Am J Gastroenterol; 2000 Oct; 95(10):2910-4. PubMed ID: 11051367
[TBL] [Abstract][Full Text] [Related]
35. The influence of hemochromatosis mutations on iron overload of thalassemia major.
Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
[TBL] [Abstract][Full Text] [Related]
36. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.
Zanella A; Bianchi P; Iurlo A; Boschetti C; Taioli E; Vercellati C; Zappa M; Fermo E; Tavazzi D; Sampietro M
Blood Cells Mol Dis; 2001; 27(3):653-61. PubMed ID: 11482880
[TBL] [Abstract][Full Text] [Related]
37. Hemochromatosis in Ireland and HFE.
Ryan E; O'keane C; Crowe J
Blood Cells Mol Dis; 1998 Dec; 24(4):428-32. PubMed ID: 9851896
[TBL] [Abstract][Full Text] [Related]
38. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
39. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
40. The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease.
Butterworth JR; Cooper BT; Rosenberg WM; Purkiss M; Jobson S; Hathaway M; Briggs D; Howell WM; Wood GM; Adams DH; Iqbal TH
Gastroenterology; 2002 Aug; 123(2):444-9. PubMed ID: 12145797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
